New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 7, 2013
07:13 EDTSVASinovac Biotech's hepatitis vaccine selected by Jiangsu Province
Sinovac Biotech has been selected by the Jiangsu Centers for Disease Control and Prevention to supply the company's inactivated hepatitis A vaccine, Healive, under the Expanded Program of Immunization in 2014 to the pediatric population in Jiangsu Province. Sinovac will supply 900,000 doses of Healive to Jiangsu province.
News For SVA From The Last 14 Days
Check below for free stories on SVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
06:09 EDTSVASinovac Biotech receives tender to supply Healive in Beijing under EPI
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use